Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 6 (2023)

Prevalence and therapeutic management of chlamydiosis in goats

Author(s):
Mahesh Kamble, Milind Meshram, Kavita Khillare, Uma Tumlam, Chandrashekhar Mote and Sameer Jadhav
Abstract:
This study aimed to assess the prevalence of Chlamydia abortus in goats from three different areas of western Maharashtra, India, with a focus on flocks with a history of abortion and weak offspring. Blood samples were collected from 150 goats for diagnosis using an iELISA test, and prevalence was evaluated based on area, sex, and age. Alterations in hematological and total protein values were estimated in seropositive goats, and DNA was extracted for PCR testing. Seropositive goats were then divided into three groups, each receiving a different antibiotic and supportive therapy for ten days. The study found that Meropenem @ 10mg/kg BW i/v was more effective in mitigating anti-chlamydial antibody titres in seropositive goats than Oxytetracycline @ 10mg/kg BW i/v and Tylosin @ 10mg/kg BW i/m. These findings suggest that Meropenem may be a promising treatment option for Chlamydia abortus infections in goats, although further research is needed to confirm these results.
Pages: 1060-1063  |  251 Views  152 Downloads


The Pharma Innovation Journal
How to cite this article:
Mahesh Kamble, Milind Meshram, Kavita Khillare, Uma Tumlam, Chandrashekhar Mote, Sameer Jadhav. Prevalence and therapeutic management of chlamydiosis in goats. Pharma Innovation 2023;12(6):1060-1063.

Call for book chapter